Cupertino, CA, United States of America

Hema S Sista

USPTO Granted Patents = 5 

Average Co-Inventor Count = 2.0

ph-index = 5

Forward Citations = 36(Granted Patents)


Company Filing History:


Years Active: 2004-2014

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Hema S Sista: Innovator in Pharmaceutical Formulations

Introduction

Hema S Sista is a notable inventor based in Cupertino, California, recognized for her contributions to the field of pharmaceutical formulations. With a total of five patents to her name, she has made significant advancements in the stability and efficacy of adeno-associated virus (AAV) compositions.

Latest Patents

Hema's latest patents focus on excipients for use in adeno-associated virus pharmaceutical formulations. These stable pharmaceutical compositions comprise recombinant AAV virions, which provide protection against the loss of recombinant AAV vector genomes and transduceability. The formulations are designed to withstand conditions such as cycles of freezing and thawing, as well as storage in glass or polypropylene vials. The compositions include recombinant AAV virions combined with one or more dihydric or polyhydric alcohols, and optionally, a detergent like a sorbitan ester. Additionally, methods of using these compositions are also described in her patents.

Career Highlights

Throughout her career, Hema has worked with prominent companies in the biotechnology sector, including Genzyme Corporation and Avigen, Inc. Her experience in these organizations has contributed to her expertise in developing innovative pharmaceutical solutions.

Collaborations

Hema has collaborated with various professionals in her field, including her coworker Yero J Espinoza, who has also made significant contributions to the industry.

Conclusion

Hema S Sista's work in the development of stable pharmaceutical compositions has positioned her as a key innovator in the field of biotechnology. Her patents reflect her commitment to advancing the efficacy of adeno-associated virus formulations, ultimately contributing to the improvement of therapeutic options in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…